Search Grant Opportunities

Consortium for Design of TB Drug Regimens (UM1 Clinical Trial Not Allowed)

ID: RFA-AI-22-059 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

The purpose of this FOA is to establish a consortium of tuberculosis (TB) preclinical and clinical experts to systematically refine preclinical models by analyses of relevant pre-clinical and clinical data, and to provide results from optimized models to identify the most promising combination regimens for clinical testing

Overview

Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 9/21/22 the National Institutes of Health posted grant opportunity RFA-AI-22-059 for Consortium for Design of TB Drug Regimens (UM1 Clinical Trial Not Allowed). The grant will be issued under grant program 93.855 Allergy and Infectious Diseases Research.

Timing

Posted Date
Sept. 21, 2022, 12:00 a.m. EDT
Closing Date
Feb. 7, 2023, 12:00 a.m. EST Past Due
Last Updated
Sept. 21, 2022, 10:29 a.m. EDT
Version
1
Archive Date
March 15, 2023

Eligibility

Eligible Applicants
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Public and State controlled institutions of higher education
County governments
City or township governments
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Special district governments
Independent school districts
For profit organizations other than small businesses
Private institutions of higher education
Small businesses
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-059.html

Documents

Posted documents for RFA-AI-22-059

Grant Awards

Grants awarded through RFA-AI-22-059

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to RFA-AI-22-059

Experts for Consortium for Design of TB Drug Regimens (UM1 Clinical Trial Not Allowed)

Recommended subject matter experts available for hire